Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease

Biochemical and Biophysical Research Communications

Volumn 405, Issue 1, 2011, Pages 42-46

  Zhang, Qiuwang ^a   Kandic, Ivana ^a   Kutryk, Michael J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Coronary artery disease; Endothelial progenitor cells; MicroRNA; Real time PCR

Indexed keywords

ATORVASTATIN; MICRORNA;

ANGIOGENESIS; ARTICLE; CARDIAC PATIENT; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PYRROLES; STEM CELLS;

EID: 79551474502     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.119     Document Type: Article

References (26)

1. Asahara T., Murohara T., Sullivan A., Silver M., Van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Shi Q., Rafii S., Wu M.H.D., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A.S., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
3. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
4. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., Martin H., Zeiher A.M., Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
5. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., Barateau V., Lecomte-Raclet L., Clergue M., Duriez M., Tobelem G., Lévy B.I. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol. 2004, 164:457-466.
6. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
7. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. Elegans. Cell 1993, 75:855-862.
8. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
9. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
10. Bartel D.P. MicroRNAs: genomics biogenesis, mechanism, and function. Cell 2004, 116:281-297.
11. Bushati N., Cohen S.M. MicroRNA functions. Annu. Rev. Cell Dev. Biol. 2007, 23:175-205.
12. Chang T.C., Mendell J.T. MicroRNAs in vertebrate physiology and human disease. Annu. Rev. Genomics Hum. Genet. 2007, 8:215-239.
13. Yang W.J., Yang D.D., Na S., Sandusky G.E., Zhang Q., Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 2005, 280:9330-9339.
14. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
15. Suárez Y., Sessa W.C. MicroRNAs as novel regulators of angiogenesis. Cir. Res. 2009, 104:442-454.
16. Bonauer A., Boon RA., Dimmeler S. Vascular microRNAs, Curr Drug Targets 2010, 11:934-939.
17. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
18. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., Srivastava D. MiR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
19. Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., Hill J.A., Richardson J.A., Bassel-Duby R., Olson E.N. The endothelial-specific microRNA MiR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15:261-271.
20. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
21. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rütten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 2001, 108:391-397.
22. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 2001, 108:399-405.
23. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., Badiwala M.V., Mickle D.A., Weisel R.D., Fedak P.W., Stewart D.J., Kutryk M.J. C-reactive protein attenuates endothelial progenitor cell survival differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004, 109:2058-2067.
24. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
25. Minami Y., Satoh M., Maesawa C., Takahashi Y., Tabuchi T., Itoh T., Nakamura M. Effect of atorvastatin on MicroRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur. J. Clin. Invest. 2009, 39:359-367.
26. Black A.E., Hayes R.N., Roth B.D., Woo P., Woolf T.F. Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab. Dispos. 1999, 27:916-923.